S&P Equity Research Downgrades Omnicare (OCR) to Strong Sell
Tweet Send to a Friend
S&P Equity Research downgrades Omnicare (NYSE: OCR) from Sell to Strong Sell.
S&P analyst, J. Englander, says, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
S&P analyst, J. Englander, says, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE